Cerebellar Ataxia with Complete Clinical Recovery and Resolution of MRI Lesions Related to Central Pontine Myelinolysis: Case Report and Literature Review by Dolciotti, Cristina et al.
 
Case Rep Neurol 2010;2:157–162 
DOI: 10.1159/000323429 
Published online: 
December 22, 2010
© 2010 S. Karger AG, Basel 
ISSN 1662–680X 
www.karger.com/crn 
This is an Open Access article licensed under the terms of the Creative Commons Attribution-
NonCommercial-NoDerivs 3.0 License (www.karger.com/OA-license), applicable to the online 
version of the article only. Distribution for non-commercial purposes only. 
 
Cristina Dolciotti, MD    Versilia Hospital, Via Aurelia 335 
IT–55043 Lucca (Italy) 
Tel. +39 0584 605 9539, Fax +39 0584 605 9537, E-Mail critstina.dolciotti @ virgilio.it 
 
157
   
Cerebellar Ataxia with 
Complete Clinical Recovery and 
Resolution of MRI Lesions 
Related to Central Pontine 
Myelinolysis: Case Report and 
Literature Review 
Cristina Dolciottib    Angelo Nutia    Gabriele Cipriania    
Paolo Borellia    Filippo Baldaccib    Chiara Logia    
Ubaldo Bonuccelli
b  
aNeurology Unit, Versilia Hospital, Camaiore, and bDepartment of Neurosciences, 
University of Pisa, Pisa, Italy 
 
Key Words 
Central pontine myelinolysis · Cerebellar ataxia · Chemotherapy · Complete recovery · 
Hyponatremia 
 
Abstract 
There are several reports of central pontine myelinolysis (CPM) in a setting of 
malnutrition, alcoholism, and chronic debilitating illness associated with electrolyte 
abnormalities, especially hyponatremia. The cause of myelinolysis is still under debate, 
and, although osmotic effects are thought to be responsible in most cases, alternative 
pathological factors should be considered [King et al.: Am J Med Sci 2010;339:561–567]. 
We report a case of CPM in a patient with recent chemotherapy for colon cancer without 
electrolyte unbalance and otherwise unexplained causes. Moreover, the present case is 
an example of the unusual clinical ataxic variant, followed by complete recovery without 
any specific treatment. The diagnosis was confirmed by MRI, which showed a 
characteristic hyperintense signal abnormality in the central part of the pons with an 
unaffected outer rim. One month later, we observed complete resolution of clinical and 
radiological symptoms. 
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Introduction 
Central pontine myelinolysis (CPM) was first described in 1959 by Adams [2] in 
patients with a history of alcohol abuse. It has been classically defined as a symmetrical 
and selective destruction of myelin sheaths in the central portion of the basis pontis, 
without evidence of an underlying vascular lesion or signs of inflammation detectable on 
MRI. 
In the clinical setting, CPM has been reported mainly in association with rapid 
correction of hyponatremia, but also in other medical conditions, such as hypernatremia, 
hypokalemia, the syndrome of inappropriate antidiuretic hormone hypersecretion 
(SIADH), liver and renal transplantation, severe liver disease, chronic alcoholism, 
malnutrition, anorexia nervosa and hyperemesis gravidarum. It has also been reported in 
association with Wernike’s encephalopathy, Wilson’s disease, brain tumors, brain edema, 
adrenal insufficiency, carcinoma and Hodgkin’s disease, chemotherapy, HIV infection, 
immunosuppression and autoimmune mechanisms. It has frequently been reported 
autoptically in asymptomatic patients [3, 4]. 
Clinical features include mental status changes, quadriparesis, pseudobulbar palsy, 
whereas cerebellar ataxia is an extremely unusual sign in CPM. We report a case of ataxia 
in CPM with a complete clinical and radiological recovery. 
Case Report 
A right-handed 74-year-old man was admitted to our hospital in May 2007 for gait disturbances for 
2 days. There was no prior history of any neurological disorder. The patient underwent partial 
colectomy for a sigma colon cancer with lung metastasis, and he received chemotherapy with 
5-fluorouracil and oxaliplatin. Neurological examination showed a significant truncal and limb ataxia 
with bilateral intention tremor. Cranial nerve function was normal, nystagmus was absent, power and 
sensory function in all 4 limbs as well as deep tendon reflexes were normal, and plantar responses were 
flexor bilaterally. Brain MRI with gadolinium showed some central pontine lesions without significant 
mass effect or contrast enhancement consistent with CPM. There were no other abnormalities in the 
rest of the brain (fig. 1). Several blood tests showed mild neutropenia, low serum levels of total 
cholesterol and albumin, but no evidence of electrolyte abnormalities (sodium: 138 mEq/l, potassium: 
3.7 mEq/l, calcium: 9.3 mg/dl, phosphorus: 4.50 mg/dl, bicarbonate: 35 mEq/l, magnesium: 1.9 mg/dl). 
The patient gradually improved without any specific treatment, and after 1 month, the neurological 
picture was back to normal. Moreover, a second brain MRI with gadolinium carried out 2 months later 
was unremarkable (fig. 2). 
Discussion 
CPM is an uncommon demyelinating disorder of unknown etiology. The mechanism 
of CPM is not well understood. Although in the original description of CPM by Adams 
there was no mention of electrolyte unbalance, it has become clear that osmotic balance is 
correlated to CPM in most cases. The factors implicated in CPM include alcohol abuse, 
malnutrition, diseases (such as chronic debilitation, cerebral ischemia, impaired fat 
metabolism, and infections), individual predisposition, dehydration, osmolarity 
fluctuations, liver dysfunction, SIADH, and prolonged diuretic use. 
Histologic studies have shown that oligodendrocytes are susceptible to CPM-related 
osmotic stress, especially making high-density brain areas, such as the central pons,  
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thalamus, cortex, putamen, lateral geniculate, and other extrapontine sites, vulnerable to 
this mechanism [1]. The neurons and axons are typically preserved, unlike in central 
pontine infections. There is no inflammatory reaction associated with osmotic 
demyelination, differentiating this process from multiple sclerosis, which is characterized 
by marked perivascular inflammation. In several reports, CPM is well described as a 
complication of chronic hyponatremia correction, especially when the correction occurs 
rapidly. Therefore, CPM is also known as osmotic demyelination syndrome, caused by 
release of toxic compounds [1–4]. 
In a recent case report, severe CPM accompanied by unusual extensive extrapontine 
myelinolysis was described in a chronic alcohol abuser without hyponatremia. The 
patient underwent methylprednisolone pulse therapy. After 7 weeks’ serial follow-up, 
MRI revealed a complete resolution of extrapontine myelinolysis, but the pons lesions 
remained unchanged [5]. In the present case, there was no evidence of electrolyte 
abnormalities. Furthermore, the clinical setting gradually improved without any 
treatment, and after 1 month the neurological picture was back to normal. 
Although we cannot rule out that our patient had suffered from minor fluctuations in 
serum sodium levels between the measurements, our patient presented with no evidence 
of hyponatremia based on the available data. On the other hand, the MRI abnormality is 
unlikely to be vascular in nature given the normal diffusion-weighted imaging sequences. 
Our case of CPM occurred in a patient with colon cancer metastasized to the lungs. 
Previously, another case of lung carcinoma and CPM was reported, but associated with 
SIADH [6]. CPM was also observed in 2 cases of nasopharyngeal carcinoma after cisplatin 
chemotherapy. This treatment is increasingly used in advanced head and neck cancers, 
and hyponatremia – usually regarded as a mild entity – is a common therapy 
complication [11]. Our patient did not develop hyponatremia after chemotherapy. 
Moreover, in our case, cerebellar symptoms were the main clinical findings. Cerebellar 
ataxia as the prevalent clinical sign of CPM is extremely rare, and it was only described in 
isolated reports (table 1) [7–14]. 
As in our patient, in all other cases of CPM with cerebellar ataxia, brain MRI with 
gadolinium revealed the presence of central pontine lesions, whereas a frontal atrophy 
and a moderate cerebellar atrophy were observed only in 1 case [13]. This neurological 
disorder is increasingly recognized, especially due to MRI, which shows the typical 
findings in the central pons: hypointense lesions in sagittal T1-weighted images and a 
triangular area hyperintense on axial T2-weighted images. 
In conclusion, in the literature, only 1 case of CPM with cerebellar ataxia in association 
with malignancy is reported; however, unlike our case, this patient presented with SIADH 
and underwent correction of hyponatremia after chemotherapy [14]. The cause of 
myelinolysis remains under debate, and although osmotic effects seem to be responsible 
in most patients, the role of malignancy should be considered because it may be more 
common than the literature suggest. 
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Table 1. Cases of CPM with ataxia 
Reference Case  Clinical   
picture 
Alcoholism/ 
malnutrition 
Electrolyte 
disturbance 
Can- 
cers 
Paraneo- 
plastic 
syndromes
Treatment Chemo- 
therapy 
Outcome MRI 
follow-up
Defebre  
et al.,  
1995 [7] 
2 ataxia, 
intention 
tremor, 
dysarthria 
yes/no hyponatremia, 
hypokalemia 
no no  hyponatremia 
correction 
no neurological 
sequelae 
CPM 
EPM1 
Gille  
et al.,  
1993 [8] 
1 ataxia, 
intention 
tremor, 
hypotonia, 
dysarthria 
yes/no hyponatremia, 
hypokalemia 
no no  hyponatremia 
correction 
no alcoholic 
dementia 
CPM 
EPM2 
Steller  
et al.,  
1988 [9] 
1 ataxia, 
intention 
tremor, 
hypotonia, 
dysarthria 
yes/no hyponatremia, 
hypokalemia 
no no  hyponatremia 
correction 
no no 
neurological 
sequelae 
CPM 
EPM1 
Rajbhandari 
et al.,  
1998 [10] 
1 ataxia, 
intention 
tremor, 
hypotonia, 
dysarthria 
yes/no hyponatremia, 
hypokalemia 
no no  hyponatremia 
correction 
no no 
neurological 
sequelae 
CPM 
EPM
1 
Menger  
and Jörg,  
1999 [11] 
2 ataxia  yes/no  Hyponatremia  no  no  hyponatremia 
correction, 
methyl-
prednisolone 
no severe  ataxia 
for 4–7 
months 
CPM 
Hagiwara 
et al.,  
2008 [12] 
1 ataxia, 
pyramidal 
spasticity, 
extrapy-
ramidal 
rigidity 
yes/no no  electrolyte 
abnormalities 
no no  methyl-
prednisolone 
no no 
neurological 
sequelae 
CPM 
(resolu-
tion 
EPM) 
Garzon et al., 
2002 [13] 
1 ataxia  yes/no  no  electrolyte 
abnormalities 
no no  no  no  no 
neurological 
sequelae 
CPM 
Yau  
et al.,  
1993 [14] 
1 ataxia, 
dysphagia, 
dysarthria 
no/no hyponatremia  yes3 SIADH  hyponatremia 
correction 
cis- 
platine 
no 
neurological 
sequelae 
CPM 
Present case 
report 
1 ataxia, 
intention  
tremor 
no/no no  electrolyte 
abnormalities 
yes4 no  no  5-fluoro-
uracil, 
oxali-
platin 
no 
neurological 
sequelae 
recov- 
ery 
1 Cerebellar peduncles. 2 Cerebellar peduncles; mild cerebellar atrophy. 3 Nasopharyngeal carcinoma. 4 Sigma-colon cancer. EPM = 
Extrapontine myelinolysis. 
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Fig. 1. Brain MRI with gadolinium proved the presence of central pontine lesions without significant 
mass effect. 
 
 
 
Fig. 2. The brain MRI in T2 flair showed the resolution of the central pontine lesions. 
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